Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
Open Access
- 1 June 1999
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 19 (6) , 624-633
- https://doi.org/10.1097/00004647-199906000-00005
Abstract
Microvascular integrity is lost during focal cerebral ischemia. The degradation of the basal lamina and extracellular matrix are, in part, responsible for the loss of vascular integrity. Matrix metalloproteinases (MMPs) may play a primary role in basal lamina degradation. By using a sensitive modification of gelatin zymography, the authors investigated the activity of MMP-2 and MMP-9 in frozen 10-µm sections of ischemic and nonischemic basal ganglia and plasma samples of 27 non-human primates after middle cerebral artery occlusion/reperfusion (MCAO/R) for various periods. The gelatinolytic activities were compared with parallel cell dUTP incorporation in the ischemic zones of adjacent sections. In the brain, the integrated density of MMP-2 increased significantly by 1 hour after MCAO and was persistently elevated thereafter. Matrix metalloproteinase-2 expression was highly correlated with the extent of neuron injury and the number of injured neurons (r = 0.9763, SE = 0.004, 2 P < 0.0008). Matrix metalloproteinase-9 expression only was significantly increased in subjects with hemorrhagic transformation. In plasma, only MMP-9 increased transiently at 2 hours of MCAO. These findings highlight the early potential role of MMP-2 in the degradation of basal lamina leading to neuronal injury, and an association of MMP-9 with hemorrhagic transformation after focal cerebral ischemia.Keywords
This publication has 46 references indexed in Scilit:
- Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemiaPublished by Elsevier ,1999
- PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery StrokeStroke, 1998
- Transcriptional Activation by p53 of the Human Type IV Collagenase (Gelatinase A or Matrix Metalloproteinase 2) PromoterMolecular and Cellular Biology, 1997
- Differential matrix metalloproteinase expression in cases of multiple sclerosis and strokeNeuropathology and Applied Neurobiology, 1997
- The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple SclerosisJournal of Neuropathology and Experimental Neurology, 1996
- Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cellsBiochemical Journal, 1996
- Mechanisms of Fibrinolysis-Associated Hemorrhagic TransformationPublished by Springer Nature ,1995
- Polymorphonuclear Leukocyte Behavior in a Nonhuman Primate Focal Ischemia ModelJournal of Cerebral Blood Flow & Metabolism, 1994
- Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction.Stroke, 1990
- Experimental acute thrombotic stroke in baboons.Stroke, 1986